Ryan Spitler
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Immunology top 5%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Phagocytosis and Immune Regulation
Papers in
-
- RNA Interference and Gene Delivery 4
-
- Nanoparticle-Based Drug Delivery 7
- Co-authors
- Saeid Zanganeh (10 shared papers)Morteza Mahmoudi (3 shared papers)Gregor Hütter (2 shared papers)Heike E. Daldrup‐Link (1 shared paper)Olga D. Lenkov (1 shared paper)Stuart B. Goodman (1 shared paper)Aubie Shaw (1 shared paper)Jukka Pajarinen (1 shared paper)
- Journals
- Molecular Imaging and Biology (2 papers)Journal of Biomedical Optics (2 papers)Science Translational Medicine (2 papers)Nature Nanotechnology (1 paper)Molecular Therapy (1 paper)
- Partner nations
- United StatesIranUnited Kingdom
In The Last Decade
Ryan Spitler
27 papers receiving 2.2k citations
Ryan Spitler's Hit Papers
Peers
Comparison fields: 5 of 138
- Biomaterials 546
- Immunology 628
- Biomedical Engineering 999
- Pharmaceutical Science 106
- Ophthalmology 85
Countries citing papers authored by Ryan Spitler
This map shows the geographic impact of Ryan Spitler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Spitler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Spitler more than expected).
Fields of papers citing papers by Ryan Spitler
This network shows the impact of papers produced by Ryan Spitler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Spitler. The network helps show where Ryan Spitler may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryan Spitler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues Hit paper breakdown → | 2016 | 1421 |
| 2 | 2016 | 147 | |
| 3 | 2018 | 145 | |
| 4 | 2010 | 119 | |
| 5 | 2010 | 73 | |
| 6 | 2021 | 64 | |
| 7 | 2010 | 47 | |
| 8 | 2017 | 39 | |
| 9 | 2013 | 28 | |
| 10 | 2013 | 26 | |
| 11 | 2014 | 25 | |
| 12 | 2011 | 22 | |
| 13 | 2010 | 19 | |
| 14 | 2015 | 17 | |
| 15 | 2013 | 14 | |
| 16 | 2011 | 13 | |
| 17 | 2017 | 11 | |
| 18 | 2017 | 9 | |
| 19 | 2017 | 6 | |
| 20 | 2017 | 6 |
About Ryan Spitler
Ryan Spitler is a scholar working on Molecular Biology, Biomaterials, Biomedical Engineering, Cardiology and Cardiovascular Medicine and Health, Toxicology and Mutagenesis, having authored 28 papers that have together received 2.3k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (7 papers), RNA Interference and Gene Delivery (4 papers), Characterization and Applications of Magnetic Nanoparticles (3 papers), Polymer Surface Interaction Studies (2 papers), Nanoparticles: synthesis and applications (2 papers), Advanced Fluorescence Microscopy Techniques (2 papers), Immune cells in cancer (2 papers) and Laser Applications in Dentistry and Medicine (2 papers). The work is most often cited by research in Biomaterials (546 citations), Immunology (628 citations), Biomedical Engineering (999 citations), Pharmaceutical Science (106 citations) and Ophthalmology (85 citations). Ryan Spitler has collaborated with scholars based in United States, Iran and United Kingdom. Frequent co-authors include Saeid Zanganeh, Morteza Mahmoudi, Gregor Hütter, Heike E. Daldrup‐Link, Olga D. Lenkov, Stuart B. Goodman, Aubie Shaw, Jukka Pajarinen, Michael E. Moseley and Lisa M. Coussens. Their work appears in journals such as Molecular Imaging and Biology, Journal of Biomedical Optics, Science Translational Medicine, Nature Nanotechnology and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.